VistaGen Therapeutics
VTGN
$4.59
Share price
-0.65%
Change (1 day)
3,430.77%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - Total debt
Total debt on the balance sheet as of December 2023 : $2.25 M
According to VistaGen Therapeutics 's latest financial reports the company's total debt is $2.25 M. A company’s total debt is the sum of all current and non-current debts.
VistaGen Therapeutics - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $2.71 M | -10.49% |
| 2022-03-31 | $3.03 M | -18.28% |
| 2021-03-31 | $3.71 M | -9.12% |
| 2020-03-31 | $4.09 M | 6043.84% |
| 2019-03-31 | $0.06 M | 1.22% |
| 2018-03-31 | $0.06 M | -4.78% |
| 2017-03-31 | $0.06 M | -3.89% |
| 2016-03-31 | $0.07 M | -99.5% |
| 2015-03-31 | $14.26 M | 106.14% |
| 2014-03-31 | $6.91 M | 29.39% |
| 2013-03-31 | $5.34 M | 49.83% |
| 2012-03-31 | $3.56 M | |
| 2010-12-31 | $0 M | 6% |
| 2009-12-31 | $0 M | 0% |
| 2008-12-31 | $0 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | 22.06% | 🇺🇸 USA |